Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP965426.RAPWSIda57Em7tZCLYIl3-dQofXLuVlJmQGWmLLc4DYpA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP965426.RAPWSIda57Em7tZCLYIl3-dQofXLuVlJmQGWmLLc4DYpA130_assertion type Assertion NP965426.RAPWSIda57Em7tZCLYIl3-dQofXLuVlJmQGWmLLc4DYpA130_head.
- NP965426.RAPWSIda57Em7tZCLYIl3-dQofXLuVlJmQGWmLLc4DYpA130_assertion description "[In advanced-stage ovarian tumors, a significant (29.3%; P<0.05) methylation frequency of FBXO32 was observed and the association between FBXO32 methylation and shorter progression-free survival was significant, as determined by both Kaplan-Meier analysis (P<0.05) and multivariate Cox regression analysis (hazard ratio: 1.003, P<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP965426.RAPWSIda57Em7tZCLYIl3-dQofXLuVlJmQGWmLLc4DYpA130_provenance.
- NP965426.RAPWSIda57Em7tZCLYIl3-dQofXLuVlJmQGWmLLc4DYpA130_assertion evidence source_evidence_literature NP965426.RAPWSIda57Em7tZCLYIl3-dQofXLuVlJmQGWmLLc4DYpA130_provenance.
- NP965426.RAPWSIda57Em7tZCLYIl3-dQofXLuVlJmQGWmLLc4DYpA130_assertion SIO_000772 20065949 NP965426.RAPWSIda57Em7tZCLYIl3-dQofXLuVlJmQGWmLLc4DYpA130_provenance.
- NP965426.RAPWSIda57Em7tZCLYIl3-dQofXLuVlJmQGWmLLc4DYpA130_assertion wasDerivedFrom befree-20150227 NP965426.RAPWSIda57Em7tZCLYIl3-dQofXLuVlJmQGWmLLc4DYpA130_provenance.
- NP965426.RAPWSIda57Em7tZCLYIl3-dQofXLuVlJmQGWmLLc4DYpA130_assertion wasGeneratedBy ECO_0000203 NP965426.RAPWSIda57Em7tZCLYIl3-dQofXLuVlJmQGWmLLc4DYpA130_provenance.